Location History:
- Shizuoka-ken, JP (1997)
- Sunto-gun, JP (2001 - 2004)
- Nagareyama, JP (2002 - 2011)
- Shizuoka, JP (1995 - 2012)
- Chiba, JP (2014 - 2017)
Company Filing History:
9 out of 730 
5 out of 850 
4 out of 272 
Years Active: 1995-2017
Title: Etsuo Ohshima: Innovator in Chemokine Receptor Antagonists
Introduction
Etsuo Ohshima, a prominent inventor based in Nagareyama, Japan, has made significant contributions to the field of pharmaceutical innovations with a focus on chemokine receptor antagonists. With a total of 23 patents to his name, Ohshima is recognized for his groundbreaking work in developing methods to treat diseases associated with aberrant leukocyte recruitment and activation.
Latest Patents
Ohshima's latest patents include innovative compounds and methods that address critical health concerns. One notable patent involves chemokine receptor antagonists that provide a new approach to treating diseases linked to abnormal leukocyte activity. The method disclosed includes administering an effective amount of a compound or its physiologically acceptable salt to individuals in need, showcasing a targeted therapeutic strategy.
Career Highlights
Etsuo Ohshima has built a successful career within the pharmaceutical industry, where he has played pivotal roles in various research initiatives. His notable work at Kyowa Hakko Kogyo Co., Ltd. has established him as a noteworthy inventor contributing to advancements in medical treatment options.
Collaborations
Throughout his career, Ohshima has collaborated with esteemed colleagues such as Jay R Luly and Yoshisuke Nakasato, leveraging their diverse expertise to enhance the effectiveness of his innovations. These collaborations have been instrumental in the development of cutting-edge therapeutic approaches.
Conclusion
Etsuo Ohshima's dedication to innovation in the field of chemokine receptor antagonists demonstrates the vital role of inventors in advancing medical science. Through his patents and collaborations, he continues to influence the landscape of pharmaceutical research, ultimately contributing to improved health outcomes. His ongoing efforts highlight the importance of inventive solutions in addressing complex medical challenges.